Literature DB >> 19075434

Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma.

Sunita Dyavanagoudar1, Alka Kale, Kishore Bhat, Seema Hallikerimath.   

Abstract

BACKGROUND: Tissue manipulation by incisions, radiotherapy, and palpation may lead to dissemination of cancer cells into circulation. Circulating cancer cells in blood play a central role in metastatic process. Their numbers can be very small and for their detection,reverse transcriptase polymerase chain reaction (RT-PCR) has been successfully used in this study.
MATERIALS AND METHODS: To examine whether cancer cell dissemination results from incision biopsy, we tried to detect oral squamous cell carcinoma (OSCC) cells in the peripheral blood sample before and after incision biopsy by CK19 RT-PCR. The study group consisted of 25 OSCC patients and the control group consisted of five patients with oral submucos fibrosis and five with leukoplakia. Five ml of blood collected before and twice (15 and 30 min) after incision were used for CK19 RT-PCR.
RESULTS: Four (16%) of 25 cases of OSCC were positive for CK19 transcripts in their peripheral blood drained 15 min after incision. CK19 transcripts were not detected in the control group.
CONCLUSION: Surgical invasion, in the form of incisional biopsy, causes dissemination of cancer cells into circulation, resulting in increased risk of metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075434     DOI: 10.4103/0970-9290.44534

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  11 in total

Review 1.  Exciting new advances in oral cancer diagnosis: avenues to early detection.

Authors:  Ravi Mehrotra; Dwijendra K Gupta
Journal:  Head Neck Oncol       Date:  2011-07-28

Review 2.  Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?

Authors:  Olga A Martin; Robin L Anderson; Kailash Narayan; Michael P MacManus
Journal:  Nat Rev Clin Oncol       Date:  2016-08-23       Impact factor: 66.675

Review 3.  Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct.

Authors:  Naveen Chhabra; Shruti Chhabra; Nitin Sapra
Journal:  J Maxillofac Oral Surg       Date:  2014-07-29

4.  Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?

Authors:  Kris R Jatana; Jas C Lang; Jeffrey J Chalmers
Journal:  Future Oncol       Date:  2011-04       Impact factor: 3.404

Review 5.  Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.

Authors:  Santiago Cabezas-Camarero; Pedro Pérez-Segura
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

6.  Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up.

Authors:  N Möckelmann; S Laban; K Pantel; R Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-14       Impact factor: 2.503

Review 7.  Squamous cell carcinoma of the oral cavity and circulating tumour cells.

Authors:  Johannes Wikner; Alexander Gröbe; Klaus Pantel; Sabine Riethdorf
Journal:  World J Clin Oncol       Date:  2014-05-10

8.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

Review 9.  Risk of tumor cell seeding through biopsy and aspiration cytology.

Authors:  K Shyamala; H C Girish; Sanjay Murgod
Journal:  J Int Soc Prev Community Dent       Date:  2014-01

10.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.